Ortin Global Limited (BOM:539287)

Market Cap	111.48M -11.2%
Revenue (ttm)	1.12M -79.6%
Net Income	-8.95M
EPS	-1.10
Shares Out	8.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20
Average Volume	2,118
Open	13.71
Previous Close	n/a
Day's Range	13.71 - 13.71
52-Week Range	10.10 - 19.15
Beta	0.55
RSI	37.13
Earnings Date	May 29, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 3
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539287

Financial Performance

In fiscal year 2025, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2024.